The first multi-gene test that can help predict cancer patients' responses to treatment using the latest DNA sequencing techniques has been launched in the NHS. The test detects mutations across 46 genes in cancer cells.
Zenalux Biomedical offers the Zenascope PC1, a biological tissue spectrometer that non-destructively measures biological tissue characteristics (biomarkers) that reflect underlying function and composition. The device is being used to detect the presence of cancer as well as other disease states and has also shown promise in monitoring therapy.
Hormonal therapies can help control advanced prostate cancer for a time. However, for most men, at some point their prostate cancer eventually stops responding to further hormonal treatment. This stage of the disease is called androgen-insensitive or castration-resistant prostate cancer.
Cancer cells break down sugars and produce the metabolic acid lactate at a much higher rate than normal cells. This phenomenon provides a telltale sign that cancer is present. Now, a team of researchers has devised a molecular sensor that can detect levels of lactate in individual cells in real time.
Researchers have identified an elusive anti-cancer property of vitamin E that has long been presumed to exist, but difficult to find.
New research performed on lab-grown human skin suggests that short but powerful bursts of THz radiation may both cause DNA damage and increase the production of proteins that help the body fight cancer.
Researchers say they have found that stem cells from a patient’s own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma.
A seemingly obscure gene in the female fruit fly that is only active in cells that will become eggs has led researchers to the discovery of an atypical protein that lures, traps and inactivates the powerful Polo kinase, widely considered the master regulator of cell division.
Despite significant advances, cancer remains one of the predominant causes of mortality in the modern world, and as such has remained a top research priority. It is a complex and continually evolving genetic disease and, as such, requires sophisticated tools for study.
Women treated with radiation for breast cancer are more likely to develop heart problems later, even with the lower doses used today, troubling new research suggests. The risk comes from any amount of radiation, starts five years after treatment and lasts for decades, doctors found.
The Food and Drug Administration has approved a new imaging drug, Lymphoseek, from Navidea Biopharmaceuticals Inc., to help doctors locate lymph nodes in patients with breast cancer and skin cancer.
A new study shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus cutting the cells’ energy source and eventually killing them.
A new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of malignant kidney cancer, according to new data.
Some cellular proteins have multiple, and occasionally opposing, functions. Researchers demonstrated that the oncogenic protein SRSF1 can also trigger a stop in cell growth and prevent cancerous proliferation by stabilizing p53, the powerful tumor-suppressor protein.
Researchers have discovered a likely origin of epithelial ovarian cancer (ovarian carcinoma), the fifth leading cause of cancer death among women in the United States.
A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.
The gene most strongly linked to obesity and overeating may also increase the risk of malignant melanoma– the most deadly skin cancer, new research reveals.
Inspired by a chemical that fungi secrete to defend their territory, chemists have synthesized and tested several dozen compounds that may hold promise as potential cancer drugs.
A multi-institutional team has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common malignant brain tumor in children.
As cancer researchers are learning more about the causes of glioblastoma tumor cell growth and drug resistance, they are discovering molecular pathways that might lead to new, targeted therapies to potentially treat this deadly cancer.
Researchers developing innovative biological and chemical techniques to image and diagnose cancer, have recently been investigating the use of magnetic beads in cancer diagnosis.
Advanced breast cancer has increased slightly among young women, a 34-year analysis suggests. The disease is still uncommon among women younger than 40, and the small change has experts scratching their heads about possible reasons. The results are potentially worrisome...
In research that could one day improve the success of stem cell transplants and chemotherapy, scientists have found that distinct niches exist in bone marrow to nurture different types of blood stem cells.
Researchers have found a new way to accelerate a workhorse instrument that identifies proteins. The high-speed technique could help diagnose cancer sooner and point to new drugs for treating a wide range of conditions.
The U.S. Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones. The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines...